Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma
- 11 November 2010
- journal article
- research article
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 49 (7) , 510-515
- https://doi.org/10.1016/j.bjoms.2010.09.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary glandLaboratory Investigation, 2009
- A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glandsOral Oncology, 2007
- Salivary gland adenoid cystic carcinoma: A review of chemotherapy and molecular therapiesPublished by Elsevier ,2006
- Imatinib Mesylate Can Induce Objective Response in Progressing, Highly Expressing KIT Adenoid Cystic Carcinoma of the Salivary GlandsJournal of Clinical Oncology, 2005
- Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium StudyJournal of Clinical Oncology, 2005
- Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated casesHead & Neck, 2004
- Adenoid cystic carcinoma of the head and neckClinical Otolaryngology, 1997
- Adenoid cystic carcinomaClinical Otolaryngology, 1986
- Adenoid cystic carcinoma: Factors influencing survivalThe American Journal of Surgery, 1979
- Salivary gland tumours and their mucinsThe Journal of Pathology and Bacteriology, 1959